Vaxcyte, Inc. (PCVX)

Vaxcyte (PCVX) Stock Price & Analysis


PCVX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$17.44 - $54.84
Previous Close$48.97
Average Volume (3M)991.49K
Market Cap
Enterprise Value$3.78B
Total Cash (Recent Filing)$822.04M
Total Debt (Recent Filing)$16.59M
Price to Earnings (P/E)-14.1
Nov 07, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.46
Shares Outstanding93,706,790
10 Day Avg. Volume674,260
30 Day Avg. Volume991,486
Standard Deviation0.20
Financial Highlights & Ratios
Price to Book (P/B)5.11
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-25.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-14.76
Price Target Upside36.14% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Vaxcyte, Inc.’s price range in the past 12 months?
Vaxcyte, Inc. lowest stock price was $17.44 and its highest was $54.84 in the past 12 months.
    What is Vaxcyte, Inc.’s market cap?
    Currently, no data Available
    When is Vaxcyte, Inc.’s upcoming earnings report date?
    Vaxcyte, Inc.’s upcoming earnings report date is Nov 07, 2023 which is in 163 days.
      How were Vaxcyte, Inc.’s earnings last quarter?
      Vaxcyte, Inc. released its earnings results on May 08, 2023. The company reported -$0.7 earnings per share for the quarter, beating the consensus estimate of -$0.822 by $0.122.
        Is Vaxcyte, Inc. overvalued?
        According to Wall Street analysts Vaxcyte, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Vaxcyte, Inc. pay dividends?
          Vaxcyte, Inc. does not currently pay dividends.
          What is Vaxcyte, Inc.’s EPS estimate?
          Vaxcyte, Inc.’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Vaxcyte, Inc. have?
          Vaxcyte, Inc. has 93,706,790 shares outstanding.
            What happened to Vaxcyte, Inc.’s price movement after its last earnings report?
            Vaxcyte, Inc. reported an EPS of -$0.7 in its last earnings report, beating expectations of -$0.822. Following the earnings report the stock price went down -0.992%.
              Which hedge fund is a major shareholder of Vaxcyte, Inc.?
              Among the largest hedge funds holding Vaxcyte, Inc.’s share is RA Capital Management. It holds Vaxcyte, Inc.’s shares valued at 273M.


                Vaxcyte Stock Smart Score

                The Vaxcyte stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                Vaxcyte, Inc.

                Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from most common and deadly diseases.


                Top 5 ETFs holding PCVX

                Market Value
                Smart Score
                Vanguard Health Care ETF
                iShares NASDAQ US Biotechnology UCITS ETF
                Fidelity MSCI Health Care Index ETF
                First Trust US Equity Opportunities ETF
                Fidelity Nasdaq Composite Index ETF
                Up to five ETFs with an Outperform Smart Score that hold PCVX. The ETFs are listed according to market value of PCVX within the ETF


                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                Intellia Therapeutics
                Vir Biotechnology

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis